Articles tagged with Cancer Treatments
A new multiple gene expression profile test can predict the presence of harmful BRCA1 or BRCA2 mutations in otherwise healthy women. The test showed a sensitivity of 95% and specificity of 88%, and has the potential to replace expensive sequencing tests, making it an affordable option for high-risk carriers.
The new age of proteomics brings a comprehensive understanding of cellular proteins, shedding light on their role in illnesses. The next-generation proteomics technology enables improved biomarker search, personalized therapies, and enhanced cancer diagnosis.
Researchers at UNC developed a method to visualize aging and tumor growth in mice using gene-activated luminescent cells. They found that old mice were brighter than young mice, with sites of cancer formation becoming extremely bright, allowing for early identification of developing cancers.
A recent study by IASLC found that EGFR mutations do not serve as a prognostic factor in NSCLC patients. Instead, smoking status appears to be the most significant predictor of overall survival. The researchers also discovered that administering EGFR TKI can prolong survival after disease recurrence.
A Kaiser Permanente study found that annual percent changes in prostate-specific antigen (PSA) levels are more accurate for detecting aggressive prostate cancer than single measurements. The study analyzed nearly 220,000 men and found a moderate increase in PSA levels with age.
Researchers at CSHL have discovered how Chd5 exerts its beneficial effects by binding to histone H3, preventing cancer initiation and promoting tumor suppression. This finding has important implications for treating diverse human cancers.
Exposure to environmental toxins can cause chronic health problems like respiratory, endocrine, reproductive, and neuropsychiatric disorders in children. Unique risk factors include their small size, developmental stage, and habit of putting things in their mouths.
A recent study found that a third of trials with no statistically significant benefit reported on secondary outcomes to influence results. Two-thirds of trials with serious side-effects under-reported them, particularly when the treatment showed a positive outcome. The authors call for improved reporting guidelines.
A recent study published in PLOS Biology has discovered the role of ELF5 in aggressive breast cancer subtypes and its potential to overcome anti-estrogen therapies. The research suggests that manipulating ELF5 levels could lead to new treatment strategies for breast cancer patients.
A preclinical study found that androgen deprivation therapies may have adverse effects on prostate cancer growth and survival in men with precancerous conditions. The study's results suggest that reducing testosterone levels may encourage indolent tumors to become more aggressive as men age.
Researchers report on the therapeutic potential of microRNAs in cancer therapy and their role as potential biomarkers for early cancer detection. The stability of miRNAs in body fluids makes them suitable for non-invasive malignancy detection methods, offering exciting opportunities for revolutionizing diagnostics and screening.
A new study published in the Journal of Urology found that robotic-assisted laparoscopic radical cystectomy (RARC) resulted in decreased estimated blood loss and shorter hospital stays compared to open radical cystectomy (ORC) for patients with muscle-invasive bladder cancer. RARC also showed a trend towards faster return of bowel func...
Researchers found ID proteins essential for retaining glioma-initiating cells in a specific extracellular niche, maintaining their cancer-promoting properties. The study's results suggest ID proteins as potential therapeutic targets for glioma treatment.
Scientists are harnessing big data analytics and genomics to tailor fertility treatments to individual women. Dr. Piraye Yurttas Beim's work at Celmatix Inc. aims to develop non-invasive diagnostic tests to identify genetic drivers of infertility, enabling personalized recommendations for effective treatments.
A recent study found immunohistochemistry to be a reliable and accurate method for detecting ALK rearrangement in non-small cell lung cancer. The technique outperformed fluorescence in situ hybridization, which is currently the standard but time-consuming method.
The conference, organized by IRB Barcelona and the BBVA Foundation, brings together experts to discuss the virtues of statistics for biomedical applications and present current state of the discipline. Biostatistics is applied to clinical assays, scrutinizing huge amounts of data and integrating information from diverse sources.
Researchers found that patients with a family history of colorectal cancer are more likely to develop tumors with low-level methylation of LINE-1, a molecular sign associated with an aggressive form of the disease. Testing for this sign may help identify patients in need of aggressive treatment and inform familial cancer-risk assessments.
Researchers have developed a novel method for screening ALK fusions in non-small cell lung carcinoma (NSCLC) that is sensitive, specific, and economical. The new test offers a high-throughput and cost-effective screening modality compared to existing tests.
A phase 3 trial by Dana-Farber Cancer Institute found an experimental drug combination for preventing graft-versus-host disease (GVHD) did not significantly improve outcomes compared to the standard regimen. The treatment had some benefits, including reduced mucositis and faster engraftment, but also increased veno-occlusive disease risk.
The study found that 71% of previously untreated older patients experienced a complete or partial response to ibrutinib treatment. After 22 months of follow-up, the disease had not progressed in 96% of previously untreated patients. Ibrutinib's potential as a highly active, well-tolerated first-line therapy for CLL is promising.
Researchers have found that nanoparticles produced by fungus A. oligospora stimulate the immune system and kill tumors, offering a potential new approach to cancer treatment. The discovery could lead to the development of novel materials for therapeutic applications.
The University of Kentucky has developed a pioneering electronic health record (EHR) reporting system for cancer cases to the state's cancer registry. This innovation enables real-time data transmission, facilitating faster trend analysis and informed statewide cancer control efforts.
A survey of over 6,200 Finns found that there is substantial disagreement about whether certain states of being should be considered diseases, influencing public funding and policy decisions. The results highlight the complexities of defining disease and its impact on social debates.
Researchers have discovered two related genes, ARID1A and ARID1B, involved in the most aggressive form of childhood cancer neuroblastoma. These findings identify a novel pathway that scientists can now study to develop potential new therapies for children with tumors having these mutations.
Researchers found ARID1A and ARID1B gene mutations in 8 patients, associated with worse survival outcomes. The discovery could lead to early identification of high-risk patients requiring additional treatments.
Women with advanced breast cancer who wait over 60 days for treatment face significantly higher risks of dying. Early detection and timely treatment can increase five-year survival rates to as high as 98 percent.
A cost-effectiveness analysis found that KRAS testing is cost-saving, while BRAF testing offers additional savings. The study suggests that molecular testing primarily generates cost savings by identifying nonresponders, rather than improving survival.
Researchers have discovered a novel mechanism by which normal stromal cells around ovarian cancer cells are converted into cancer-promoting cells. Altering microRNA expression in these cells enhances tumor growth and metastasis, providing new potential therapeutic targets.
A new discovery reveals that chromatin remodeling complexes (CRCs) are intrinsically turned on, requiring specific instructions to turn them off. This finding has significant implications for understanding how CRC mutations contribute to cancer development.
Aerobic exercise can help relieve fatigue associated with cancer and treatment, balancing rest with physical activity may reduce fatigue. The new review adds 28 studies, including those in breast cancer patients, showing that aerobic exercise benefits those with solid tumours during and after treatment.
The 2012 Collegiate Inventors Competition awarded over $100,000 to students for their groundbreaking inventions in medical devices, cancer therapies, and more. Inanc Ortac's Nano-Wiffle-Balls for Cancer Therapy and Leslie Myint's FastStitch suturing device were among the top winners.
A drug originally developed to prevent organ rejection has been shown to dramatically reduce a particular kind of brain tumor in patients with tuberous sclerosis complex (TSC). The study found that 35% of patients experienced at least a 50% reduction in tumor volume after treatment with everolimus.
Researchers found that a protein called TGFβig-h3 is impaired in patients with gastric cancer, allowing cancer to spread. This discovery could lead to the development of new therapies restoring the functions of this protein.
A new study found that black patients with kidney cancer have a survival disadvantage compared to white patients, even when diagnosed at early stages or receiving less aggressive treatment. The study analyzed nearly 40,000 renal cell carcinoma patients and confirmed poorer survival rates for blacks.
The UT Arlington physics team has developed a novel thermoelectric generator using copper sulfide nanoparticles and single-walled carbon nanotubes. The technology, which can convert both light and thermal energy into electrical current, shows increases of up to 80% in light absorption compared to earlier methods.
Moffitt Cancer Center researchers have identified novel metabolic signatures in glioma, a type of tumor that starts in the brain. These findings may pave the way for personalized therapy and prognostic value.
Researchers use antisense technology to target cancer cell metabolic process, killing cancer cells by blocking production of pyruvate kinase splice-variant. The approach shows therapeutic promise in treating various types of cancer.
Researchers have identified a new molecular marker, β2-syntrophin, which can help differentiate between low-risk and high-risk types of prostate cancer. This breakthrough discovery could lead to more accurate diagnoses and personalized treatment plans, ultimately improving patient outcomes.
Researchers found oxidative stress in an animal model of alpha-1-antitrypsin deficiency, which may benefit from antioxidant treatment. The study identifies potential alterations in gene expression pathways that could modify disease development.
Researchers have identified three novel genes - CHD4, FBXW7 and SPOP - that are frequently altered in serous endometrial cancer, a rare and aggressive form of uterine cancer. These findings may lead to new therapeutic targets for this devastating disease.
A recent study has found that non-Hispanic black women diagnosed with estrogen receptor-positive tumors have a significantly increased risk for breast cancer death, particularly within the first three years after diagnosis. This risk is more pronounced among black women compared to non-Hispanic white women.
Claudia R. Baquet, M.D., M.P.H., is being honored for her contributions to cancer health disparities research. She will deliver the third annual AACR Distinguished Lecture on The Science of Cancer Health Disparities.
Palliative care discussions can improve symptoms, stress, and survival time for patients with terminal illnesses. Physicians should discuss palliative care with patients during initial talks about prognosis and at subsequent visits to help them plan their remaining lives.
A recent study published in Menopause found that about one-third of women who stopped taking the SSRI antidepressant escitalopram experienced a relapse of hot flashes and night sweats. Women with insomnia and those who responded less well to the medication were more likely to experience a relapse.
Scientists at CU-Boulder have discovered the cellular targets of the Hepatitis B virus, including proteins Bcl-2 and Bcl-xL. This breakthrough could lead to new treatments for liver disease in millions of people infected with the virus, many of whom lack access to effective treatment.
Treating chronic hepatitis C with antiviral drugs could reduce liver cancer risk by half, according to a meta-analysis of published research. In some cases, treatment can even prevent the development of hepatocellular carcinoma, the most common form of liver cancer worldwide.
A randomized trial of over 14,000 male physicians found that long-term daily multivitamin use resulted in a modest but statistically significant reduction in cancer incidence. The study suggests that multivitamins may have a greater benefit on more clinically relevant cancer diagnoses.
Achieving and maintaining a healthy body weight, staying physically active, and following a healthy diet significantly reduced mortality in elderly female cancer survivors. Researchers found that adherence to lifestyle guidelines resulted in an almost 40% lower risk for death compared to those who did not follow these recommendations.
Scientists have identified a new type of stem cell that can generate new blood vessels, offering new possibilities for treating cardiovascular disease and cancer. The discovery could lead to the development of new therapeutics to prevent or stimulate neoangiogenesis.
A new study found that EMR before RFA is a safe and effective treatment option for patients with nodular Barrett's esophagus and advanced neoplasia. The performance of EMR before RFA was not associated with a diminished likelihood of success or increased stricture rate compared to RFA alone.
A common birth control device has been shown to be effective in treating early-stage endometrial cancer, particularly in morbidly obese and high-risk patients. The intrauterine device releases progestin levonorgestrel, successfully used as a contraceptive for the past decade, and successfully reversed abnormal cell growth in all patients.
A study published in the Journal of Thoracic Oncology found that fit elderly patients with non-small cell lung cancer can benefit from salvage targeted therapy without increased toxicity. The study analyzed data from 255 patients and showed no difference in response rates or progression-free survival between age groups.
Researchers at the University of Sheffield have found an antibody treatment that not only stops PAH from worsening but also reverses the condition in mice and rats. The discovery offers new hope for patients suffering from this devastating disease.
Researchers at UMass Amherst have found a way to deliver bio-active cargo such as proteins and synthetic molecules into naïve T cells using a new synthetic protein transduction domain. This breakthrough enables the study of crucial immune functions and holds great potential for therapeutic applications in the clinic.
A new study by TGen, Mayo Clinic and SHC demonstrated the power of whole genome sequencing in advancing understanding of pancreatic cancer. The research identified 142 cellular genetic coding events, including mutations, insertions and deletions, in three patients with pancreatic adenocarcinoma.
A new report reveals that mental illnesses and addictions have a significant impact on the health of Ontarians, with depression having the highest burden. The report highlights the need for treatment and reduced stigma to address this issue.
A new approach to lung scanning, called parametric response mapping, allows for better distinction between early-stage small airway disease and emphysema in patients with chronic obstructive pulmonary disease (COPD). The technique enables precise diagnosis and treatment planning, as well as tracking COPD progression over time.
Researchers found that B-Raf and C-Raf proteins are crucial for melanocyte stem cell renewal, leading to progressive whitening of fur in mice. The study provides insights into the role of these proteins in cancer development and offers potential new strategies for treating melanoma.
A new gene test has been developed to detect pre-cancerous cells in patients with benign-looking mouth lesions. The test shows a cancer detection rate of 91-94% and could potentially allow at-risk patients to receive earlier treatment, significantly improving their chance of survival.
A set of evidence-based clinical practice guidelines has been established to guide the diagnosis and treatment of low-back pain in the US. The guidelines recommend careful observation, over-the-counter pain medication, and targeted physical activity for most patients, while reserving imaging and surgery for specific cases with red flags.